Abivax S.A. Equity
Abivax S.A. (ABVX) had Equity of EUR 455.20 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-23
- 2025-12-31: Equity 455.20M EUR.
- 2025-09-30: Equity 511.24M EUR.
- 2025-06-30: Equity -48.28M EUR.
- 2025-03-31: Equity -6.59M EUR.
| Period end | Equity |
|---|---|
| 2025-12-31 | 455.20M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 511.24M EUR 6-K · filed 2025-12-15 |
| 2025-06-30 | -48.28M EUR 6-K · filed 2025-09-08 |
| 2025-03-31 | -6.59M EUR 6-K · filed 2025-06-02 |
| 2024-12-31 | 40.58M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 75.88M EUR 6-K · filed 2025-12-15 |
| 2024-06-30 | 126.47M EUR 6-K · filed 2025-09-08 |
| 2024-03-31 | 158.87M EUR 6-K · filed 2025-06-02 |
| 2023-12-31 | 196.01M EUR 20-F · filed 2026-03-23 |
| 2022-12-31 | 7.19M EUR 20-F · filed 2026-03-23 |
| 2021-12-31 | 25.93M EUR 20-F · filed 2025-03-24 |
| 2020-12-31 | 1.73M EUR 20-F · filed 2024-04-05 |